A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
Clinical trial NCT01511913 · COMPLETED
Trial details
- NCT number
- NCT01511913
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-06-03
- Primary completion
- 2018-03-30
- Enrollment
- 1411
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.